Evidence map›Paper›PMID 33642348›Full record

ArticleThe Indian journal of medical research

Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.

Ritu Gupta, Tanima Dwivedi, Smeeta Gajendra, Biswajeet Sahoo, Sanjeev Kumar Gupta, H Vikas, Angel Rajan Singh, Anant Mohan, Sushma Bhatnagar, Sheetal Singh and 2 more

Open access · diamondAbstract read
In one paragraph

Article in The Indian journal of medical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. SARS-CoV-2 Seroprevalence Among Whole Blood Donors During First Wave of Covid-19 Pandemic in India.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Authors' response.The Indian journal of medical research · 2021
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Ritu GuptaLaboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.
Tanima DwivediLaboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.
Smeeta GajendraLaboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.
Biswajeet SahooLaboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.
Sanjeev Kumar GuptaLaboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.
H VikasDepartment of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Angel Rajan SinghDepartment of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Anant MohanDepartment of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
Sushma BhatnagarDepartment of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
Sheetal SinghDepartment of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Laxmitej WundavalliDepartment of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
Randeep GuleriaDepartment of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
All India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & objectives: Healthcare workers (HCWs) are considered to be at a high risk of contracting COVID-19 infection. Besides, control of nosocomial infections transmitted from HCWs to the patients is also a cause of concern. This study was undertaken to investigate the seroprevalence of antibodies against the SARS-CoV-2 virus among the hospital staff of a tertiary care health facility in north India. Methods: The HCWs were tested for SARS-CoV-2 serology (IgG+IgM) using chemiluminescence immunoassay between June 22 and July 24, 2020. Venous blood (2 ml) was collected and tested for SARS-CoV-2 IgG and IgM antibodies. Results: Of the 3739 HCWs tested, 487 (13%) were positive for total SARS-CoV-2 antibodies. The highest seroprevalence was observed in administrative staff (19.6%) and least in physicians (5.4%). The staff who used public (20%) and hospital transportation (16.9%) showed higher seroprevalence compared to staff using personal transportation (12.4%). No difference was observed between HCWs posted in COVID versus non-COVID areas. All seropositive symptomatic HCWs in our study (53.6%) had mild symptoms, and the remaining 46.4 per cent were asymptomatic. The antibody positivity rate progressively increased from 7.0 per cent in the first week to 18.6 per cent in the fourth week during the study. Interpretation & conclusions: The presence of antibodies to SARS-CoV-2 in a significant number of asymptomatic HCWs, association with the use of public transport, relatively lower seroprevalence compared with the non-HCWs and rising trend during the period of the study highlight the need for serosurveillance, creating awareness for infection control practices including social distancing and study of infection dynamics in the community for effective control of an infectious pandemic.

Indexed as

Health PersonnelInfection ControlAntibodies, ViralCOVID-19HumansImmunoglobulin GImmunoglobulin MIndiaSARS-CoV-2Seroepidemiologic StudiesTertiary Health CareAntibodies, ViralImmunoglobulin GImmunoglobulin MHealthcare workershigh riskimmunoassaypandemicSARS-CoV-2seroprevalence

Identifiers

PMID33642348
PMCPMC8184075
OpenAlexW3134358318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.